Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes

Karpe, 1994, Postprandial lipoproteins and the progression of coronary atherosclerosis, Atherosclerosis, 106, 83, 10.1016/0021-9150(94)90085-X Tkac, 1997, The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles, Arterioscler Thromb Vasc Biol, 17, 3633, 10.1161/01.ATV.17.12.3633 Sakata, 1998, Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery, Atherosclerosis, 136, 225, 10.1016/S0021-9150(97)00209-8 Curtin, 1994, Alterations in apolipoprotein B-48 in the post-prandial state in NIDDM, Diabetologia, 37, 1259, 10.1007/BF00399800 Curtin, 1995, Intestinally derived lipoprotein particles in non-insulin-dependent diabetic patients with and without hypertriglyceridaemia, Acta Diabetol, 32, 244, 10.1007/BF00576257 Demann, 1996, Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis, Eur J Clin Invest, 26, 89, 10.1046/j.1365-2362.1996.114256.x Karpe, 1999, Postprandial lipoprotein metabolism and atherosclerosis, J Intern Med, 246, 341, 10.1046/j.1365-2796.1999.00548.x Patsch, 1984, A key for the conversion of high density lipoprotein 2 into high density lipoprotein 3 by hepatic lipase, J Clin Invest, 74, 2017, 10.1172/JCI111624 Patsch, 1992, Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state, Arterioscler Thromb, 12, 1336, 10.1161/01.ATV.12.11.1336 Rasmussen, 1996, Differential effects of saturated and monounsaturated fat on blood glucose and insulin responses in subjects with non-insulin-dependent diabetes mellitus, Am J Clin Nutr, 63, 249, 10.1093/ajcn/63.2.249 Thomsen, 1999, Differential effects of saturated and monounsaturated fatty acids on postprandial lipaemia and GIP/GLP-1 responses in healthy subjects, Am J Clin Nutr, 69, 1135, 10.1093/ajcn/69.6.1135 1980 Andersen, 1993, Enzyme immunoassay for intact human insulin in serum or plasma, Clin Chem, 39, 578, 10.1093/clinchem/39.4.578 Krarup, 1983, Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type 1 (insulin dependent) diabetics, J Clin Endocrinol Metab, 56, 1306, 10.1210/jcem-56-6-1306 Hvidberg, 1994, Effect of glucagon-like peptide-1 (proglucagon 78–107 amide) on hepatic glucose production in healthy man, Metabolism, 43, 104, 10.1016/0026-0495(94)90164-3 Ørskov, 1991, Proglucagon products in plasma from non-insulin dependent diabetics and non-diabetic controls in the fasting state and following oral glucose and intravenous arginine, J Clin Invest, 87, 415, 10.1172/JCI115012 Ørskov, 1992, Structure of human GLP-1 (glucagon-like peptide-1) containing peptides, Diabetologia, 35, A109 Matthews, 1990, Analysis of serial measurements in medical research, BMJ, 300, 230, 10.1136/bmj.300.6719.230 Todd, 1998, Subcutaneous glucagon-like peptide-I improves postprandial glycemic control over a 3-week period in patients with early type 2 diabetes, Clin Sci, 95, 325, 10.1042/cs0950325 Juntti-Berggren, 1996, The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients, Diabetes Care, 19, 1200, 10.2337/diacare.19.11.1200 Willms, 1996, Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7–36) amide in type 2 (noninsulin-dependent) diabetic patients, J Clin Endocrinol Metab, 81, 327 Vaag, 1996, Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)—evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins, Eur J Endocrinol, 135, 425, 10.1530/eje.0.1350425 Vilsboll, 2001, Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients, Diabetes, 50, 609, 10.2337/diabetes.50.3.609 Brynes, 2000, Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes, Am J Clin Nutr, 72, 1111, 10.1093/ajcn/72.5.1111 Rocca, 1995, Stereospecific effects of fatty acids on proglucagon-derived peptide secretion in fetal rat intestinal cultures, Endocrinology, 136, 5593, 10.1210/endo.136.12.7588313 Rocca, 2001, Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1, Endocrinology, 142, 1148, 10.1210/endo.142.3.8034 Fielding, 1996, Postprandial lipaemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals, Am J Clin Nutr, 63, 36, 10.1093/ajcn/63.1.36 Villanueva-Penacarrillo, 2001, Effect of GLP-1 on lipid metabolism in human adipocytes, Horm Metab Res, 33, 73, 10.1055/s-2001-12428 Bertin, 2001, Action of glucagon and glucagon-like peptide-1-(7–36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo, J Clin Endocrinol Metab, 86, 1229 Toft-Nielsen, 1999, Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients, Diabetes Care, 22, 1137, 10.2337/diacare.22.7.1137 Nordenstrom, 1991, Effect of medium- and long-chain triglyceride infusion on lipoprotein and hepatic lipase in healthy subjects, Eur J Clin Invest, 21, 580, 10.1111/j.1365-2362.1991.tb01412.x Peterson, 1990, Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport, Proc Natl Acad Sci U S A, 87, 909, 10.1073/pnas.87.3.909 Thiebaud, 1983, Stimulation of thermogenesis in men after combined glucose-long-chain triglyceride infusion, Am J Clin Nutr, 37, 603, 10.1093/ajcn/37.4.603 Bonanome, 1989, Intestinal absorption of stearic acid after consumption of high fat meals in humans, J Nutr, 119, 1556, 10.1093/jn/119.11.1556 Dougherty, 1995, Effects of diets containing high or low amounts of stearic acid on plasma lipoprotein fractions and fecal fatty acid excretion of men, Am J Clin Nutr, 61, 1120, 10.1093/ajcn/61.5.1120 Jones, 1985, Absorption of 13C-labeled stearic, oleic, and linoleic acids in humans: application to breath tests, J Lab Clin Med, 105, 647 Jones, 1999, Effect of fatty acid chain length and saturation on the gastrointestinal handling and metabolic disposal of dietary fatty acids in women, Br J Nutr, 81, 37, 10.1017/S0007114599000124